madman
Super Moderator
Conclusion
*we concluded that the scrotal administration of testosterone in a cream formulation provides high bioavailability, dose-dependant peak serum testosterone concentration, and tolerability with a much lower dose relative to the non-scrotal transdermal route
*further studies of extended duration will be required to fully evaluate the clinical application of this new scrotal testosterone formulation
*we concluded that the scrotal administration of testosterone in a cream formulation provides high bioavailability, dose-dependant peak serum testosterone concentration, and tolerability with a much lower dose relative to the non-scrotal transdermal route
*further studies of extended duration will be required to fully evaluate the clinical application of this new scrotal testosterone formulation